Winning in Indian Healthcare

As India’s pharmaceutical market gears up to exceed $120 billion by 2030, the "Winning in Indian Healthcare" report by BCG and OPPI delves deep into the dynamic forces reshaping this critical sector. Against a backdrop of rapid economic growth, transformative government policies, and digital health innovations like e-pharmacies and telemedicine, the report unpacks India’s unique healthcare potential. From case studies of successful strategies to expert insights from global pharma leaders, the narrative highlights how companies can overcome challenges such as regulatory complexities, fragmented payers, and price pressures.

India’s healthcare story is a compelling juxtaposition: the rising demand driven by an aging population, a burgeoning middle class, and a chronic disease burden that accounts for over 65% of health issues. Meanwhile, groundbreaking innovations in patient access, localized products, and partnerships are transforming care delivery. To thrive in this evolving landscape, global pharma players must localize products, invest in access initiatives, and embrace digital transformation. This report serves as a strategic guide, showing how to navigate India’s vibrant but challenging healthcare ecosystem.